LongRiver Investments is a global venture capital fund with approximately USD 400 million under management, focused on private equity investments in healthcare and technology sectors across Greater China and overseas companies with a China angle. With a founding team originating from Asia’s top insurance group and bringing extensive experience from leading financial institutions, LongRiver combines deep industry knowledge with disciplined investing expertise. Our LP base includes leading global financial institutions and top-ranked asset managers, further strengthening our network and resources. Recognized in 2024 as one of Asia’s largest emerging venture capital firms, LongRiver has rapidly established a global presence spanning APAC, the US, and Europe. Leveraging strong connections with early biotech founders, clinical experts, and multinational dealmakers, we source differentiated assets and actively support cross-border BD transactions. Guided by over 15 years of healthcare industry experience, we are committed to uncovering long-term opportunities, delivering sustainable growth, and creating lasting value for our investors. The name “LongRiver” embodies this vision of navigating dynamic markets while providing certainty and resilience.